Coastal Bridge Advisors’s Kite Pharma, Inc. KITE Stock Holding History

Coastal Bridge Advisors’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-225,140	Closed	-$21.4M	–	127
2017 Q2	$21.4M	Sell	225,140 -10,000	-4%	-$816K	7.18%	5
2017 Q1	$18.5M	Sell	235,140 -14,900	-6%	-$921K	6.29%	5
2016 Q4	$11.2M	Hold	250,040	–	–	4.36%	5
2016 Q3	$14M	Hold	250,040	–	–	6.8%	3
2016 Q2	$12.5M	Hold	250,040	–	–	6.53%	3
2016 Q1	$11.5M	Hold	250,040	–	–	8.02%	2
2015 Q4	$15.4M	Buy	+250,040	New	+$17.6M	8.6%	2

Other funds holding KITE

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCSAM

Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Coastal Bridge Advisors's KITE Position: Q3 2017 in Review

Coastal Bridge Advisors sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 225,140 shares — an estimated $21.4M sold.

Coastal Bridge Advisors first reported a position in KITE in Q4 2015 and held it in 7 quarters. The position peaked at $21.4M in Q2 2017. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

Coastal Bridge Advisors reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
Coastal Bridge Advisors sold 225,140 Kite Pharma, Inc. shares in Q3 2017, an estimated $21.4M.
Coastal Bridge Advisors first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 7 quarters.
Coastal Bridge Advisors's Kite Pharma, Inc. position peaked at $21.4M in Q2 2017.
244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Coastal Bridge Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.